Compare Stocks

Star Diamond Corporation engages in the exploration, development, and production of diamonds in Canada. The company's principal mineral properties include the Star Kimberlite property and the Orion South Kimberlite property located in Fort à la Corne area of Saskatchewan, Canada. It also holds a 50% interest in the Buffalo Hills project located in north central Alberta, Canada. The company was formerly known as Shore Gold Inc. and changed its name to Star Diamond Corporation in February 2018. The company was incorporated in 1985 and is headquartered in Saskatoon, Canada.

Falco Resources Ltd. engages in the exploration, evaluation, and development of mineral properties in Canada. It explores for base and precious metals, as well as gold, zinc, copper, and silver deposits. The company owns mining claims and contractual rights in relation to mining concessions covering an area of approximately 70,000 hectares of land in the Rouyn-Noranda mining camp located in the Province of Québec. Its principal asset includes the Horne 5 Project located in the former Horne mine. The company was formerly known as Falco Pacific Resource Group Inc. and changed its name to Falco Resources Ltd. in July 2014. Falco Resources Ltd. was incorporated in 2010 and is headquartered in Montreal, Canada.

The Goldman Sachs Access Emerging Markets USD Bond ETF (GEMD) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund tracks a market value-weighted index of USD-denominated emerging markets government bonds of various credit quality and maturity. Bonds are selected by multiple economic factors such as governance indicators, import coverage, and inflation. GEMD was launched on Feb 15, 2022 and is managed by Goldman Sachs.

Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.